A detailed history of Jump Financial, LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Jump Financial, LLC holds 101,975 shares of RLAY stock, worth $458,887. This represents 0.02% of its overall portfolio holdings.

Number of Shares
101,975
Holding current value
$458,887
% of portfolio
0.02%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.23 - $9.51 $635,304 - $969,782
101,975 New
101,975 $721,000
Q1 2024

May 13, 2024

BUY
$7.5 - $12.07 $77,370 - $124,514
10,316 New
10,316 $85,000
Q3 2023

Oct 21, 2024

SELL
$8.24 - $12.97 $109,699 - $172,669
-13,313 Reduced 11.43%
103,194 $867,000
Q3 2023

Nov 07, 2023

SELL
$8.24 - $12.97 $109,699 - $172,669
-13,313 Reduced 11.43%
103,194 $867,000
Q2 2023

Oct 21, 2024

BUY
$9.99 - $18.27 $1.16 Million - $2.13 Million
116,507 New
116,507 $1.46 Million
Q2 2023

Aug 07, 2023

BUY
$9.99 - $18.27 $1.16 Million - $2.13 Million
116,507 New
116,507 $1.46 Million
Q4 2022

Feb 13, 2023

BUY
$14.16 - $24.02 $1.31 Million - $2.22 Million
92,413 New
92,413 $1.38 Million
Q1 2022

May 12, 2022

SELL
$20.26 - $32.36 $216,782 - $346,252
-10,700 Closed
0 $0
Q4 2021

Feb 10, 2022

SELL
$26.0 - $37.03 $1.54 Million - $2.2 Million
-59,400 Reduced 84.74%
10,700 $329,000
Q3 2021

Nov 12, 2021

BUY
$29.75 - $37.99 $1.55 Million - $1.97 Million
51,975 Added 286.76%
70,100 $2.21 Million
Q2 2021

Aug 13, 2021

BUY
$27.5 - $38.19 $498,437 - $692,193
18,125 New
18,125 $663,000

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $541M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.